9.1 Amino Acid Hormones Flashcards
1
Q
describe amino acid hormones action via cAMP secondary messenger
A
- hormone binds, causes Gs to activate and bind to the receptor
- GDP comes off GTP comes on
- GTP bound Gs activates adenylate cyclase
- ATP -> cAMP to activation PKA to trigger target cell response
- PDE is used to turn off the pathway, cAMP -> 5’AMP
*can also have an inhibitory hormone that binds, activates Gi to inhibt adenylate cyclase
2
Q
what can activation of cAMP do
A
- cause action via phosphotylation (PKA)
- act via a direct effect (cAMP-GEF/Epac)
3
Q
describe amino acid action via PIP2 mechanism
A
4
Q
describe amino action based hormone action with the PIP2 mechanism
A
- Hormone binds, Gq associates with it
- GDP comes off and GTP comes on
- GTP activates Phospholipase C (cleaves PIP2 in membrane forming DAG and IP3
- DAG inercaats with PKC and activates it -> trigers target cell response
- IP3 interacts with ER and binds IP3 receptors to release Ca2+
- Calcium binds to calmodulin and then triggers response in target cell
5
Q
MOA of steriod hormones
A
*all are membrane permeable and need a carrier protein
- steriod hormone diffuses in and binds to the receptor-chaperonin complex
- receptors dissociate, then receoptor homone complex bings to hormone response elements on DNA
- will be a lag between effects because gene transcription takes some time to get going, but then will form mRNA that is sent out of the nucelous to be translated into protein
*steriord hormone will activate a bunch of gene targets
6
Q
all steriod hormones activate genes
A
FALSE
- can also have some immediate efects
7
Q
A
8
Q
steriod hormones for treatment of breast cancer
A
- Estrogen receptor E2 involved in breast cancer
- can block binding of E2 by changing the shape of receptor complex (tamoxifen, raloxifene
- can do corepressor binding, clocks interation of 2 receptors at the gene level
- can use antiestrogens to stop receptor shuttling and cause receptor destruction
9
Q
what is herceptin
A
- HER2 (human epidermal growth factor receptor 2) positive metastatic breast cancer have a more aggressive disease
- greater likelihood of recurrence, poorer prognosis and appoex 1/2 life expectancy o owmen with NER2 neg breast cancer
- Herceptin (Trastuzumab): antibody treatment of women with HER2 pos metastatic breast cancer
- one of few therapies and only humanized antibody with deomonstrated survivial benefit
*blcoks dimerization and targets for immune destruction